Hypertension effective treatment coverage (controlled hypertension) in New Zealand
New Zealand: Hypertension effective treatment coverage (controlled hypertension) was 27.4% in 2019. ▲ Rising
Hypertension effective treatment coverage (controlled hypertension) in New Zealand, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
New Zealand recorded 27.4% for hypertension effective treatment coverage (controlled hypertension) in 2019.
That represents a change of down 0.7% on the previous year and up 4.2% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in New Zealand peaked at 28.2% in 2014 and was at its lowest, 8.4%, in 1990.
That places New Zealand 45th out of 193 countries with data for 2019, putting it in the top quarter.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension effective treatment coverage (controlled hypertension) in New Zealand, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 8.4% | — |
| 1991 | 8.7% | +3.6% |
| 1992 | 9.1% | +4.6% |
| 1993 | 9.6% | +5.5% |
| 1994 | 10.2% | +6.2% |
| 1995 | 10.9% | +6.9% |
| 1996 | 11.7% | +7.3% |
| 1997 | 12.5% | +6.8% |
| 1998 | 13.5% | +8.0% |
| 1999 | 14.5% | +7.4% |
| 2000 | 15.6% | +7.6% |
| 2001 | 16.8% | +7.7% |
| 2002 | 18.0% | +7.1% |
| 2003 | 19.3% | +7.2% |
| 2004 | 20.7% | +7.3% |
| 2005 | 22.1% | +6.8% |
| 2006 | 23.3% | +5.4% |
| 2007 | 24.5% | +5.2% |
| 2008 | 25.4% | +3.7% |
| 2009 | 26.3% | +3.5% |
| 2010 | 26.9% | +2.3% |
| 2011 | 27.5% | +2.2% |
| 2012 | 27.8% | +1.1% |
| 2013 | 28.1% | +1.1% |
| 2014 | 28.2% | +0.4% |
| 2015 | 28.1% | -0.4% |
| 2016 | 28.0% | -0.4% |
| 2017 | 27.8% | -0.7% |
| 2018 | 27.6% | -0.7% |
| 2019 | 27.4% | -0.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 10.9% | 8.4% | 14.5% | 10 |
| 2000s | 21.2% | 15.6% | 26.3% | 10 |
| 2010s | 27.7% | 26.9% | 28.2% | 10 |
Countries ranked near New Zealand
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in New Zealand?
- Hypertension effective treatment coverage (controlled hypertension) in New Zealand was 27.4% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in New Zealand?
- The highest recorded value was 28.2% in 2014.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in New Zealand?
- The lowest recorded value was 8.4% in 1990.
- How does New Zealand rank for hypertension effective treatment coverage (controlled hypertension)?
- New Zealand ranks 45th out of 193 countries with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in New Zealand?
- Over the last ten years it is up 4.2%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).